|
US3108046A
(en)
|
1960-11-25 |
1963-10-22 |
Smith Kline French Lab |
Method of preparing high dosage sustained release tablet and product of this method
|
|
US3870790A
(en)
*
|
1970-01-22 |
1975-03-11 |
Forest Laboratories |
Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
|
|
US4175125A
(en)
|
1971-12-27 |
1979-11-20 |
Eli Lilly And Company |
Method for treating methicillin resistant staphylococcus aureus
|
|
GB1472534A
(en)
*
|
1973-07-06 |
1977-05-04 |
Glaxo Lab Ltd |
7beta-hydroxyiminoacylamido-cephalosporins
|
|
NZ177159A
(en)
|
1974-04-20 |
1978-03-06 |
Beecham Group Ltd |
Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
|
|
US4529720A
(en)
|
1974-04-20 |
1985-07-16 |
Beecham Group, P.L.C. |
Antibiotic from Streptomyces clavulicerus
|
|
JPS5119765A
(en)
|
1974-08-09 |
1976-02-17 |
Takeda Chemical Industries Ltd |
Aminochiazoorujudotaino seizoho |
|
AT342770B
(de)
|
1975-04-07 |
1978-04-25 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer erythromycinderivate
|
|
US6048977C1
(en)
*
|
1975-04-17 |
2001-10-16 |
Smithkline Beecham Plc |
Clavulanic acid and salts thereof
|
|
US6218380B1
(en)
*
|
1975-04-17 |
2001-04-17 |
Smithkline Beecham P.L.C. |
Pharmaceutical compositions
|
|
US4018918A
(en)
*
|
1975-05-20 |
1977-04-19 |
The Upjohn Company |
Topical clindamycin preparations
|
|
US4131672A
(en)
|
1975-06-09 |
1978-12-26 |
Eli Lilly And Company |
Method for treating methicillin resistant Staphylococcus aureus
|
|
US4250166A
(en)
*
|
1977-05-27 |
1981-02-10 |
Shionogi & Co., Ltd. |
Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
|
|
US4236211A
(en)
|
1978-09-15 |
1980-11-25 |
Pfizer Inc. |
Method and apparatus for determining the minimum concentration of antibiotic necessary to at least inhibit microorganism growth
|
|
US4226849A
(en)
|
1979-06-14 |
1980-10-07 |
Forest Laboratories Inc. |
Sustained release therapeutic compositions
|
|
FR2470599A1
(fr)
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
|
US4331803A
(en)
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
|
US4399151A
(en)
|
1980-06-16 |
1983-08-16 |
Merrell Dow Pharmaceuticals Inc. |
Method of inhibiting the growth of protozoa
|
|
US4362731A
(en)
|
1980-09-01 |
1982-12-07 |
Sandoz Ltd. |
Myotonolytic use of 4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridin-3-ol and derivatives thereof
|
|
IL64009A
(en)
|
1980-10-31 |
1984-09-30 |
Rech Applications Therap |
Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them
|
|
EP0052075A1
(de)
|
1980-11-12 |
1982-05-19 |
Ciba-Geigy Ag |
Körnige Arzneimittel-Retardform
|
|
US4435495A
(en)
*
|
1980-11-17 |
1984-03-06 |
Eastman Kodak Company |
Release of photographic reagents with 3-pyrazolidone developing agents
|
|
YU43006B
(en)
|
1981-03-06 |
1989-02-28 |
Pliva Pharm & Chem Works |
Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
|
|
US4369172A
(en)
*
|
1981-12-18 |
1983-01-18 |
Forest Laboratories Inc. |
Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
|
|
US4435173A
(en)
|
1982-03-05 |
1984-03-06 |
Delta Medical Industries |
Variable rate syringe pump for insulin delivery
|
|
US4474768A
(en)
|
1982-07-19 |
1984-10-02 |
Pfizer Inc. |
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
|
|
US4598045A
(en)
|
1982-08-25 |
1986-07-01 |
Hana Biologics, Inc. |
Triphasic mycoplasmatales detection method
|
|
US4430495A
(en)
*
|
1982-09-17 |
1984-02-07 |
The Upjohn Company |
Process for preparing lincomycin and clindamycin ribonucleotides
|
|
JPS601128A
(ja)
*
|
1983-06-15 |
1985-01-07 |
Shionogi & Co Ltd |
作用持続型セフアクロル製剤
|
|
AU575854B2
(en)
*
|
1983-10-04 |
1988-08-11 |
Shionogi & Co., Ltd. |
7beta-(carboxyalkenamido) cephalosporins
|
|
DE3405378A1
(de)
*
|
1984-02-15 |
1985-08-22 |
Röhm GmbH, 6100 Darmstadt |
Arzneimittelueberzug
|
|
JPS60214796A
(ja)
|
1984-04-06 |
1985-10-28 |
Taisho Pharmaceut Co Ltd |
６−０−メチルエリスロマイシン類の製法
|
|
US4616008A
(en)
|
1984-05-02 |
1986-10-07 |
Takeda Chemical Industries, Ltd. |
Antibacterial solid composition for oral administration
|
|
US4568741A
(en)
*
|
1984-05-15 |
1986-02-04 |
The Upjohn Company |
Synthesis of 7-halo-7-deoxylincomycins
|
|
US4879135A
(en)
|
1984-07-23 |
1989-11-07 |
University Of Medicine And Dentistry Of New Jersey |
Drug bonded prosthesis and process for producing same
|
|
JPS61103890A
(ja)
|
1984-10-26 |
1986-05-22 |
Taisho Pharmaceut Co Ltd |
６−０−メチルエリスロマイシンａ誘導体
|
|
CN1004002B
(zh)
|
1984-11-29 |
1989-04-26 |
厄普约翰公司 |
制备7-卤-7-去氧林可霉素及其类似化合物的改进方法
|
|
EP0188040B1
(en)
|
1985-01-11 |
1991-08-14 |
Abbott Laboratories Limited |
Slow release solid preparation
|
|
JPS61210025A
(ja)
*
|
1985-03-14 |
1986-09-18 |
Teisan Seiyaku Kk |
安定化された抗生物質複合顆粒製剤
|
|
US4670549A
(en)
|
1985-03-18 |
1987-06-02 |
Taisho Pharmaceutical Co., Ltd. |
Method for selective methylation of erythromycin a derivatives
|
|
US4894119A
(en)
*
|
1985-04-10 |
1990-01-16 |
Drew Chemical Corporation |
Retention and/or drainage and/or dewatering aid
|
|
US4728512A
(en)
*
|
1985-05-06 |
1988-03-01 |
American Home Products Corporation |
Formulations providing three distinct releases
|
|
US4775751A
(en)
|
1985-06-03 |
1988-10-04 |
Eli Lilly & Company |
Process for cephalexin hydrochloride alcoholates
|
|
DE3524572A1
(de)
|
1985-07-10 |
1987-01-15 |
Thomae Gmbh Dr K |
Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
|
|
FR2585948B1
(fr)
|
1985-08-06 |
1988-12-16 |
Pf Medicament |
Procede de fabrication de comprimes d'indometacine
|
|
JPH0778017B2
(ja)
*
|
1985-12-28 |
1995-08-23 |
住友製薬株式会社 |
パルス的かつ持続放出性製剤
|
|
US4794001A
(en)
|
1986-03-04 |
1988-12-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
|
US4904476A
(en)
*
|
1986-03-04 |
1990-02-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
|
LU87041A1
(fr)
|
1987-11-04 |
1989-06-14 |
Oreal |
Esters retinoiques de macrolides,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
|
|
US4723958A
(en)
*
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
|
GB8613689D0
(en)
|
1986-06-05 |
1986-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
NZ220764A
(en)
*
|
1986-07-02 |
1989-09-27 |
Shionogi & Co |
Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
|
|
KR960000434B1
(ko)
*
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
|
JPS63162619A
(ja)
*
|
1986-12-25 |
1988-07-06 |
Teisan Seiyaku Kk |
遅溶性顆粒及びそれを用いた持続性複合顆粒
|
|
US4749568A
(en)
|
1987-01-23 |
1988-06-07 |
The Upjohn Company |
Rubradirin treatment of methicillin-resistant staph
|
|
US4806359A
(en)
*
|
1987-04-22 |
1989-02-21 |
Mcneilab, Inc. |
Iburprofen sustained release matrix and process
|
|
US5200193A
(en)
|
1987-04-22 |
1993-04-06 |
Mcneilab, Inc. |
Pharmaceutical sustained release matrix and process
|
|
US4945405A
(en)
|
1987-05-21 |
1990-07-31 |
Minolta Camera Kabushiki Kaisha |
Color image read apparatus with shading and color balance correction
|
|
US5143661A
(en)
|
1987-05-26 |
1992-09-01 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules
|
|
US4945080A
(en)
|
1987-05-26 |
1990-07-31 |
Eli Lilly And Company |
Dirithromycin metabolite
|
|
US4808411A
(en)
*
|
1987-06-05 |
1989-02-28 |
Abbott Laboratories |
Antibiotic-polymer compositions
|
|
US5110597A
(en)
|
1987-06-25 |
1992-05-05 |
Alza Corporation |
Multi-unit delivery system
|
|
US4835140A
(en)
|
1987-08-20 |
1989-05-30 |
Indiana University Foundation |
Method for treating pneumocystis carinii pneumonia patients with clindamycin and primaquine
|
|
US4915953A
(en)
*
|
1987-09-03 |
1990-04-10 |
Alza Corporation |
Dosage form for delivering acetaminophen or phenylpropanolamine
|
|
SE457230B
(sv)
*
|
1987-11-13 |
1988-12-12 |
Eva Margareta Axelsson Stenstr |
Odontologiskt instrument foer rengoering och avplaning av tandrotsytor
|
|
US4971805A
(en)
|
1987-12-23 |
1990-11-20 |
Teysan Pharmaceuticals Co., Ltd. |
Slow-releasing granules and long acting mixed granules comprising the same
|
|
JP2751385B2
(ja)
|
1988-05-19 |
1998-05-18 |
大正製薬株式会社 |
エリスロマイシンａオキシム及びその塩の製造方法
|
|
US4849515A
(en)
|
1988-08-22 |
1989-07-18 |
E. I. Du Pont De Nemours And Company |
Clindamycin-2-phosphoryl benzylate
|
|
US4895934A
(en)
|
1988-08-22 |
1990-01-23 |
E. I. Du Pont De Nemours And Company |
Process for the preparation of clindamycin phosphate
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5110598A
(en)
|
1989-06-30 |
1992-05-05 |
Smithkline Beecham Corp. |
Intermittent release dosage form
|
|
US5178874A
(en)
*
|
1989-06-30 |
1993-01-12 |
Smithkline Beechman Corporation |
Intermittent release dosage form
|
|
IL95423A
(en)
|
1989-09-21 |
1994-11-11 |
American Cyanamid Co |
Pulsatile once-a-day delivery systems for minocycline
|
|
DK469989D0
(da)
|
1989-09-22 |
1989-09-22 |
Bukh Meditec |
Farmaceutisk praeparat
|
|
US5204055A
(en)
*
|
1989-12-08 |
1993-04-20 |
Massachusetts Institute Of Technology |
Three-dimensional printing techniques
|
|
US5387380A
(en)
*
|
1989-12-08 |
1995-02-07 |
Massachusetts Institute Of Technology |
Three-dimensional printing techniques
|
|
JPH0674206B2
(ja)
*
|
1989-12-28 |
1994-09-21 |
田辺製薬株式会社 |
放出制御型製剤およびその製法
|
|
US5229131A
(en)
|
1990-02-05 |
1993-07-20 |
University Of Michigan |
Pulsatile drug delivery system
|
|
US5158777A
(en)
|
1990-02-16 |
1992-10-27 |
E. R. Squibb & Sons, Inc. |
Captopril formulation providing increased duration of activity
|
|
US5358713A
(en)
|
1990-02-23 |
1994-10-25 |
Mitsui Norin Co., Ltd. |
Method of preventing the transmission of infection caused by methicillin-resistant Staphylococcus aureus
|
|
US5182374A
(en)
|
1990-03-21 |
1993-01-26 |
American Cyanamid Company |
Clindamycin phosphate synthesis
|
|
GEP19971086B
(en)
*
|
1991-02-22 |
1997-12-02 |
Tillotts Pharma Ag |
Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
|
|
US5556839A
(en)
|
1991-04-29 |
1996-09-17 |
Eli Lilly And Company |
Form II Dirithromycin
|
|
GB9109862D0
(en)
*
|
1991-05-08 |
1991-07-03 |
Beecham Lab Sa |
Pharmaceutical formulations
|
|
US5326570A
(en)
*
|
1991-07-23 |
1994-07-05 |
Pharmavene, Inc. |
Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
|
|
SK293592A3
(en)
|
1991-09-30 |
1998-08-05 |
Eli Lilly And Company Patent D |
One step process for production of dirithromycin
|
|
US5334590A
(en)
|
1991-10-17 |
1994-08-02 |
Merck & Co., Inc. |
MRSA active 2-phenyl-carbapenems
|
|
US5476854A
(en)
|
1991-11-27 |
1995-12-19 |
Sepracor Inc. |
Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
|
|
US5260066A
(en)
*
|
1992-01-16 |
1993-11-09 |
Srchem Incorporated |
Cryogel bandage containing therapeutic agent
|
|
US6117843A
(en)
|
1992-02-18 |
2000-09-12 |
Lloyd J. Baroody |
Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
|
|
TW203552B
(en)
*
|
1992-02-18 |
1993-04-11 |
J Baroody Lloyd |
Compositions of clindamycin and benzoyl peroxide for acne treatment
|
|
JP3265680B2
(ja)
*
|
1992-03-12 |
2002-03-11 |
大正製薬株式会社 |
経口製剤用組成物
|
|
US5230703A
(en)
|
1992-04-09 |
1993-07-27 |
Staodyn, Inc. |
Wound infection resolution utilizing antibiotic agents and electrical stimulation
|
|
EP0642344B1
(en)
*
|
1992-04-30 |
1997-03-19 |
Schering Corporation |
Stable hydrated cephalosporin dry powder for oral suspension formulation
|
|
US5260068A
(en)
*
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
|
TW271400B
(enExample)
|
1992-07-30 |
1996-03-01 |
Pfizer |
|
|
MX9304638A
(es)
|
1992-07-31 |
1994-05-31 |
Neose Pharm Inc |
Composicion para tratar e inhibir las ulceras gastricas y duodenales.
|
|
US5817321A
(en)
|
1992-10-08 |
1998-10-06 |
Supratek Pharma, Inc. |
Biological agent compositions
|
|
US5688516A
(en)
|
1992-11-12 |
1997-11-18 |
Board Of Regents, The University Of Texas System |
Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
|
|
US5260069A
(en)
*
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
|
US5422343A
(en)
|
1992-12-21 |
1995-06-06 |
Otsuka Pharmaceutical Factory, Inc. |
Prophylactic and therapeutic composition for MRSA infection
|
|
JP3319800B2
(ja)
*
|
1993-02-01 |
2002-09-03 |
辻本化学工業株式会社 |
抗耐性黄色ブドウ球菌化合物
|
|
US5414014A
(en)
|
1993-04-08 |
1995-05-09 |
Innova Biomed, Inc. |
Methods for efficacious removal of attached, sucking antropods from human dermis
|
|
WO1996010996A1
(en)
|
1993-07-21 |
1996-04-18 |
The University Of Kentucky Research Foundation |
A multicompartment hard capsule with control release properties
|
|
WO1995003052A1
(en)
|
1993-07-22 |
1995-02-02 |
Warner-Lambert Company |
Controlled release tacrine drug delivery systems and methods for preparing same
|
|
CA2101241C
(en)
|
1993-07-23 |
1998-12-22 |
Jonathan P. Wong |
Liposome-encapsulated ciprofloxacin
|
|
US5538954A
(en)
|
1994-06-24 |
1996-07-23 |
A/S Dumex (Dumex Ltd.) |
Salts of tetracyclines
|
|
US6183778B1
(en)
*
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
|
US6280771B1
(en)
*
|
1997-02-20 |
2001-08-28 |
Therics, Inc. |
Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
|
|
US5490962A
(en)
*
|
1993-10-18 |
1996-02-13 |
Massachusetts Institute Of Technology |
Preparation of medical devices by solid free-form fabrication methods
|
|
US5518680A
(en)
|
1993-10-18 |
1996-05-21 |
Massachusetts Institute Of Technology |
Tissue regeneration matrices by solid free form fabrication techniques
|
|
US6251647B1
(en)
|
1993-12-06 |
2001-06-26 |
The Rockefeller University |
Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
|
|
WO1995016039A1
(en)
|
1993-12-06 |
1995-06-15 |
The Rockefeller University |
Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
|
|
US5457187A
(en)
|
1993-12-08 |
1995-10-10 |
Board Of Regents University Of Nebraska |
Oligonucleotides containing 5-fluorouracil
|
|
US5393765A
(en)
*
|
1993-12-13 |
1995-02-28 |
Hoffmann-La Roche Inc. |
Pharmaceutical compositions with constant erosion volume for zero order controlled release
|
|
DE4404018A1
(de)
*
|
1994-02-09 |
1995-08-10 |
Merck Patent Gmbh |
Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat
|
|
US5466446A
(en)
|
1994-02-16 |
1995-11-14 |
Stiefel Laboratories, Inc. |
Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
|
|
US5430021A
(en)
|
1994-03-18 |
1995-07-04 |
Pharmavene, Inc. |
Hydrophobic drug delivery systems
|
|
US5395626A
(en)
*
|
1994-03-23 |
1995-03-07 |
Ortho Pharmaceutical Corporation |
Multilayered controlled release pharmaceutical dosage form
|
|
PL316633A1
(en)
|
1994-04-01 |
1997-02-03 |
Microcide Pharmaceuticals |
Cephalosporin antibiotics
|
|
GB9407386D0
(en)
*
|
1994-04-14 |
1994-06-08 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
GB9408117D0
(en)
|
1994-04-23 |
1994-06-15 |
Smithkline Beecham Corp |
Pharmaceutical formulations
|
|
US5856474A
(en)
|
1994-04-25 |
1999-01-05 |
Biochemie Gesellschaft, M.B.H. |
Cephalosporin synthesis
|
|
EP0758244B2
(en)
|
1994-05-06 |
2008-02-13 |
Pfizer Inc. |
Controlled-release dosage forms of azithromycin
|
|
FR2722098B1
(fr)
|
1994-07-06 |
1996-08-23 |
Cird Galderma |
Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
|
|
GB9416600D0
(en)
|
1994-08-17 |
1994-10-12 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
US5543417A
(en)
|
1994-10-21 |
1996-08-06 |
Merck & Co., Inc. |
Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
|
|
US5827531A
(en)
|
1994-12-02 |
1998-10-27 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Microcapsules and methods for making
|
|
US5872104A
(en)
*
|
1994-12-27 |
1999-02-16 |
Oridigm Corporation |
Combinations and methods for reducing antimicrobial resistance
|
|
US5702895A
(en)
|
1995-01-19 |
1997-12-30 |
Wakunaga Seiyaku Kabushiki Kaisha |
Method and kit for detecting methicillin-resistant Staphylococcus aureus
|
|
US20030083733A1
(en)
|
1997-10-10 |
2003-05-01 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5567441A
(en)
|
1995-03-24 |
1996-10-22 |
Andrx Pharmaceuticals Inc. |
Diltiazem controlled release formulation
|
|
EP0826376B1
(en)
|
1995-05-02 |
2007-01-24 |
Taisho Pharmaceutical Co. Ltd |
Composition for oral administration
|
|
US5755753A
(en)
|
1995-05-05 |
1998-05-26 |
Thermage, Inc. |
Method for controlled contraction of collagen tissue
|
|
US6057291A
(en)
|
1995-06-02 |
2000-05-02 |
University Of British Columbia |
Antimicrobial cationic peptides
|
|
US6132768A
(en)
|
1995-07-05 |
2000-10-17 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
|
|
US5945124A
(en)
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
|
US6136587A
(en)
|
1995-07-10 |
2000-10-24 |
The Rockefeller University |
Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
|
|
US5985643A
(en)
|
1996-07-10 |
1999-11-16 |
The Rockefeller University |
Auxiliary gene and protein of methicillin resistant bacteria and antagonists thereof
|
|
US6013507A
(en)
*
|
1995-07-10 |
2000-01-11 |
The Rockefeller University |
Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
|
|
US6548084B2
(en)
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
|
US5780058A
(en)
|
1995-07-21 |
1998-07-14 |
Alza Corporation |
Oral delivery of discrete units
|
|
US5919489A
(en)
|
1995-11-01 |
1999-07-06 |
Abbott Laboratories |
Process for aqueous granulation of clarithromycin
|
|
US5872229A
(en)
*
|
1995-11-21 |
1999-02-16 |
Abbott Laboratories |
Process for 6-O-alkylation of erythromycin derivatives
|
|
US5756473A
(en)
|
1995-11-21 |
1998-05-26 |
Abbott Laboratories |
6-O-methyl erythromycin D and process for making
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
US5705190A
(en)
*
|
1995-12-19 |
1998-01-06 |
Abbott Laboratories |
Controlled release formulation for poorly soluble basic drugs
|
|
US5998194A
(en)
|
1995-12-21 |
1999-12-07 |
Abbott Laboratories |
Polyketide-associated sugar biosynthesis genes
|
|
SE9600072D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral formulation of two active ingredients II
|
|
CA2242660A1
(en)
|
1996-02-16 |
1997-08-21 |
The Regents Of The University Of California |
Antimicrobial peptides and methods of use
|
|
JP3957338B2
(ja)
|
1996-02-23 |
2007-08-15 |
株式会社カイノス |
診断薬
|
|
US5951588A
(en)
|
1996-02-29 |
1999-09-14 |
Moenning; Stephen P. |
Apparatus and method for protecting a port site opening in the wall of a body cavity
|
|
US5766220A
(en)
*
|
1996-02-29 |
1998-06-16 |
Moenning; Stephen P. |
Apparatus and method for protecting a port site opening in the wall of a body cavity
|
|
TWI225402B
(en)
|
1996-03-13 |
2004-12-21 |
Biochemie Gmbh |
Auxiliary-free agglomerates
|
|
US5719272A
(en)
*
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
|
US5837829A
(en)
|
1996-04-02 |
1998-11-17 |
Abbott Laboratories |
9-oximesilyl erythromycin a derivatives
|
|
US5808017A
(en)
|
1996-04-10 |
1998-09-15 |
Abbott Laboratories |
Process for preparing erythromycin A oxime
|
|
US5719132A
(en)
*
|
1996-06-27 |
1998-02-17 |
Bristol-Myers Squibb Company |
Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
|
|
US5780446A
(en)
|
1996-07-09 |
1998-07-14 |
Baylor College Of Medicine |
Formulations of vesicant drugs and methods of use thereof
|
|
US5858986A
(en)
*
|
1996-07-29 |
1999-01-12 |
Abbott Laboratories |
Crystal form I of clarithromycin
|
|
US5844105A
(en)
|
1996-07-29 |
1998-12-01 |
Abbott Laboratories |
Preparation of crystal form II of clarithromycin
|
|
GB9617780D0
(en)
*
|
1996-08-24 |
1996-10-02 |
Smithkline Beecham Plc |
Method of treatment
|
|
WO1998011906A1
(en)
|
1996-09-17 |
1998-03-26 |
Amur Pharmaceuticals, Inc. |
Phospholipid drug derivatives
|
|
IL119627A
(en)
|
1996-11-17 |
2002-03-10 |
Yissum Res Dev Co |
PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
|
|
US5840760A
(en)
|
1996-11-19 |
1998-11-24 |
Florida Atlantic University |
materials and methods for controlling methicillin-resistant Staphylococcus aureus microbes
|
|
IT1289160B1
(it)
*
|
1997-01-08 |
1998-09-29 |
Jagotec Ag |
Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
|
|
US5945405A
(en)
|
1997-01-17 |
1999-08-31 |
Abbott Laboratories |
Crystal form O of clarithromycin
|
|
US6296873B1
(en)
|
1997-01-23 |
2001-10-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Zero-order sustained release delivery system for carbamazephine derivatives
|
|
US5980942A
(en)
|
1997-01-23 |
1999-11-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Zero-order sustained release matrix tablet formulations of carbamazepine
|
|
US5864023A
(en)
*
|
1997-02-13 |
1999-01-26 |
Abbott Laboratories |
3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
|
|
US6551616B1
(en)
*
|
1997-04-11 |
2003-04-22 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
|
US6010718A
(en)
*
|
1997-04-11 |
2000-01-04 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
|
US20050064033A1
(en)
*
|
1997-04-11 |
2005-03-24 |
Notario Gerard F. |
Extended release formulations of erythromycin derivatives
|
|
US6210710B1
(en)
*
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
DE19718012C1
(de)
*
|
1997-04-29 |
1998-10-08 |
Jenapharm Gmbh |
Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe
|
|
US6406880B1
(en)
|
1997-05-02 |
2002-06-18 |
Integrated Research Technology, Llc |
Betaines as adjuvants to susceptibility testing and antimicrobial therapy
|
|
US5877243A
(en)
*
|
1997-05-05 |
1999-03-02 |
Icet, Inc. |
Encrustation and bacterial resistant coatings for medical applications
|
|
US5840329A
(en)
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
|
EP0998271B3
(en)
*
|
1997-06-06 |
2014-10-29 |
Depomed, Inc. |
Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
AUPO758297A0
(en)
|
1997-06-27 |
1997-07-24 |
Rowe, James Baber |
Control of acidic gut syndrome
|
|
US6503709B1
(en)
*
|
1997-07-03 |
2003-01-07 |
Id Biomedical Corporation |
Methods for rapidly detecting methicillin resistant staphylococci
|
|
US6265394B1
(en)
|
1997-07-31 |
2001-07-24 |
Bristol-Myers Squibb Company |
Bis quaternary MRSA cephem derivatives
|
|
US6630498B2
(en)
|
1997-08-06 |
2003-10-07 |
Smithkline Beecham Corporation |
Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
|
|
CA2297055A1
(en)
|
1997-08-07 |
1999-02-18 |
Research Corporation Technologies, Inc. |
Antibiotic for methicillin resistant bacteria
|
|
AU8699298A
(en)
|
1997-08-11 |
1999-03-01 |
Alza Corporation |
Prolonged release active agent dosage form adapted for gastric retention
|
|
US5929219A
(en)
|
1997-09-10 |
1999-07-27 |
Abbott Laboratories |
9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
|
|
US5892079A
(en)
*
|
1997-10-17 |
1999-04-06 |
Sri International |
Metallocene catalysts and associated methods of preparation and use
|
|
US6605751B1
(en)
|
1997-11-14 |
2003-08-12 |
Acrymed |
Silver-containing compositions, devices and methods for making
|
|
US6558699B2
(en)
|
1997-11-17 |
2003-05-06 |
Smithkline Beecham Corporation |
High drug load immediate and modified release oral dosage formulations and processes for their manufacture
|
|
US5852180A
(en)
|
1997-11-17 |
1998-12-22 |
Abbott Laboratories |
Chemical synthesis of 6-O-alkyl erythromycin A
|
|
US5932710A
(en)
|
1997-12-01 |
1999-08-03 |
Abbott Laboratories |
Process for preparing 6-O-alkyl-9-oxime erythromycin B
|
|
IL135792A0
(en)
|
1997-12-01 |
2001-05-20 |
Abbott Lab |
6-o-alkyl derivatives of erythronolide b
|
|
US5892008A
(en)
|
1997-12-16 |
1999-04-06 |
Abbott Laboratories |
Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
|
|
SE9704870D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
|
US6294526B1
(en)
|
1998-02-06 |
2001-09-25 |
Alps Pharmaceutical Ind. Co., Ltd. |
Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA
|
|
US6231875B1
(en)
|
1998-03-31 |
2001-05-15 |
Johnson & Johnson Consumer Companies, Inc. |
Acidified composition for topical treatment of nail and skin conditions
|
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
|
US6288212B1
(en)
|
1998-08-28 |
2001-09-11 |
The University Of British Columbia |
Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
|
|
KR100377159B1
(ko)
*
|
1998-09-09 |
2003-08-19 |
한미약품공업 주식회사 |
잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
|
|
US6479496B1
(en)
|
1998-09-10 |
2002-11-12 |
Cv Therapeutics, Inc. |
Methods for treating angina with ranolazine
|
|
US6740664B2
(en)
|
1998-09-30 |
2004-05-25 |
Alcon, Inc. |
Methods for treating otic and ophthalmic infections
|
|
DE19845358A1
(de)
|
1998-10-02 |
2000-04-06 |
Roehm Gmbh |
Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
|
|
US6384081B2
(en)
|
1998-10-09 |
2002-05-07 |
Charles L. Berman |
Treatment of diseases of the eye characterized by the formation of metalloproteinase
|
|
US20010055613A1
(en)
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
|
HU230454B1
(hu)
|
1998-11-02 |
2016-07-28 |
Alkermes Pharma Ireland Limited |
Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény
|
|
US6270805B1
(en)
|
1998-11-06 |
2001-08-07 |
Andrx Pharmaceuticals, Inc. |
Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
|
|
DE19852192C2
(de)
|
1998-11-12 |
2003-04-24 |
Bayer Ag |
Wirkstoffhaltige aromatische Copolyester
|
|
US6159491A
(en)
|
1999-02-12 |
2000-12-12 |
Biovector Technologies, Inc. |
Prolonged release bioadhesive vaginal gel dosage form
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6477410B1
(en)
|
2000-05-31 |
2002-11-05 |
Biophoretic Therapeutic Systems, Llc |
Electrokinetic delivery of medicaments
|
|
US7127285B2
(en)
|
1999-03-12 |
2006-10-24 |
Transport Pharmaceuticals Inc. |
Systems and methods for electrokinetic delivery of a substance
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US7250176B1
(en)
|
1999-04-13 |
2007-07-31 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection
|
|
US6294199B1
(en)
*
|
1999-04-13 |
2001-09-25 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising administering amoxycillin
|
|
US6878386B1
(en)
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
|
WO2000066125A1
(en)
|
1999-04-29 |
2000-11-09 |
Aventis Pharma S.A. |
Method for treating cancer using camptothecin derivatives and 5-fluorouracil
|
|
US6187768B1
(en)
*
|
1999-06-01 |
2001-02-13 |
Becton, Dickinson And Company |
Kit for flushing medical devices and method of preparation
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US6946458B2
(en)
|
1999-07-22 |
2005-09-20 |
University Of South Florida |
N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
|
|
TWI232111B
(en)
|
1999-08-06 |
2005-05-11 |
Upjohn Co |
Intravaginal clindamycin ovule composition
|
|
DE19938704C1
(de)
*
|
1999-08-14 |
2001-10-31 |
Ivoclar Vivadent Ag |
Verfahren zur Herstellung von Reaktionssystemen zur Implantation in den menschlichen und tierischen Körper als Knochenersatz, die u.a. Calcium und Phosphor enthalten
|
|
KR100322313B1
(ko)
|
1999-10-21 |
2002-02-06 |
민경윤 |
클라리스로마이신 결정형 2의 제조방법 및 이에 사용되는 클라리스로마이신 포르메이트
|
|
EP1233768A1
(en)
*
|
1999-11-15 |
2002-08-28 |
Smithkline Beecham |
Carvedilol methanesulfonate
|
|
US6627743B1
(en)
|
1999-12-03 |
2003-09-30 |
Abbott Laboratories |
6-O-methylerythromycin A crystal form III
|
|
CN1666991A
(zh)
|
1999-12-16 |
2005-09-14 |
特瓦制药工业有限公司 |
克拉霉素多晶型物的制备方法和新的多晶型物ⅳ
|
|
CN1450903A
(zh)
*
|
2000-01-11 |
2003-10-22 |
特瓦制药工业有限公司 |
克拉霉素多晶型物的制备方法
|
|
JP2004508278A
(ja)
*
|
2000-01-20 |
2004-03-18 |
デルシス ファーマシューティカル コーポレイション |
多段薬物投与形態
|
|
US6284235B1
(en)
|
2000-02-11 |
2001-09-04 |
National Starch And Chemical Company Investment Holding Corporation |
Bioadhesive composition
|
|
US6667042B2
(en)
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Fluroquinilone antibiotic product, use and formulation thereof
|
|
US6632453B2
(en)
|
2000-02-24 |
2003-10-14 |
Advancis Pharmaceutical Corp. |
Ciprofoxacin-metronidazole antibiotic composition
|
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
|
US7025989B2
(en)
|
2000-02-24 |
2006-04-11 |
Advancis Pharmaceutical Corp. |
Multiple-delayed released antibiotic product, use and formulation thereof
|
|
WO2001062229A1
(en)
*
|
2000-02-24 |
2001-08-30 |
Advanced Pharma, Inc. |
Therapeutic product, use and formulation thereof
|
|
US6991807B2
(en)
*
|
2000-02-24 |
2006-01-31 |
Advancis Pharmaceutical, Corp. |
Antibiotic composition
|
|
US6663890B2
(en)
*
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Metronidazole antibiotic product, use and formulation thereof
|
|
US6730320B2
(en)
*
|
2000-02-24 |
2004-05-04 |
Advancis Pharmaceutical Corp. |
Tetracycline antibiotic product, use and formulation thereof
|
|
US6667057B2
(en)
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Levofloxacin antibiotic product, use and formulation thereof
|
|
US6663891B2
(en)
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Erythromyacin antibiotic product, use and formulation thereof
|
|
US6610328B2
(en)
*
|
2000-02-24 |
2003-08-26 |
Advancis Pharmaceutical Corp. |
Amoxicillin-clarithromycin antibiotic composition
|
|
AU2001239841B2
(en)
*
|
2000-02-24 |
2006-04-27 |
Shionogi, Inc. |
Antibiotic and antifungal compositions
|
|
US6623758B2
(en)
|
2000-02-24 |
2003-09-23 |
Advancis Pharmaceutical Corp. |
Cephalosporin-metronidazole antibiotic composition
|
|
US6669948B2
(en)
*
|
2000-02-24 |
2003-12-30 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
US6627222B2
(en)
|
2000-02-24 |
2003-09-30 |
Advancis Pharmaceutical Corp. |
Amoxicillin-dicloxacillin antibiotic composition
|
|
US20020004070A1
(en)
*
|
2000-02-24 |
2002-01-10 |
Rudnic Edward M. |
Antineoplastic product, use and formulation thereof
|
|
US6638532B2
(en)
|
2000-02-24 |
2003-10-28 |
Advancis Pharmaceutical Corp. |
Tetracycline—doxycycline antibiotic composition
|
|
CA2401571A1
(en)
|
2000-02-29 |
2001-09-07 |
Ilya Avrutov |
Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
|
|
DE60122791T2
(de)
*
|
2000-03-15 |
2007-10-04 |
Hanmi Pharm. Co., Ltd. |
Verfahren zur Herstellung von Clarythromycin mit nicht pharmazeutischer Qualität
|
|
US6306436B1
(en)
|
2000-04-28 |
2001-10-23 |
Teva Pharmaceuticals Usa, Inc. |
Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
|
|
EP1292381B1
(en)
|
2000-05-03 |
2009-07-15 |
D'SILVA, Joe |
Process and device for producing liquid dosage formulations
|
|
ES2257412T3
(es)
|
2000-05-18 |
2006-08-01 |
Therics, Inc. |
Encapsulacion de un nucleo toxico en una region no toxica en una forma de dosificacion oral.
|
|
AU2001272935A1
(en)
*
|
2000-05-31 |
2001-12-11 |
Mayo Foundation For Medical Education And Research |
Cobalamin compounds useful as antibiotic agents and as imaging agents
|
|
PE20020044A1
(es)
|
2000-06-16 |
2002-01-30 |
Upjohn Co |
Tiazina oxazolidinona
|
|
AU2001268564A1
(en)
|
2000-06-22 |
2002-01-02 |
The Brigham And Women's Hospital, Inc. |
Alpha-glycosylceramides for treating bacterial and fungal infections
|
|
US6375982B1
(en)
|
2000-07-05 |
2002-04-23 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and method of using same
|
|
EP1301177A2
(en)
|
2000-07-10 |
2003-04-16 |
Therics, Inc. |
Method and materials for controlling migration of binder liquid in a powder
|
|
US6696426B2
(en)
*
|
2000-08-22 |
2004-02-24 |
Pharmacia Corporation |
Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
|
|
IN192748B
(enExample)
|
2000-08-29 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
|
US6767899B1
(en)
|
2000-08-29 |
2004-07-27 |
Leiner Health Services Corp. |
Composition and method for treatment of conditions having an inflammatory component
|
|
AU2001291526A1
(en)
*
|
2000-09-22 |
2002-04-02 |
Galephar M/F |
Sustained release composition containing clarithromycin
|
|
US20020103261A1
(en)
|
2000-10-06 |
2002-08-01 |
Dusan Ninkov |
Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
|
|
AR031135A1
(es)
|
2000-10-10 |
2003-09-10 |
Upjohn Co |
Composiciones de antibiotico topico para el tratamiento de infecciones oculares
|
|
US6756057B2
(en)
|
2000-10-12 |
2004-06-29 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillin and potassium clavulanate dosage form
|
|
US6541014B2
(en)
*
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
|
US7105174B2
(en)
|
2000-10-13 |
2006-09-12 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-neoplastic product, use and formulation thereof
|
|
US7108859B2
(en)
|
2000-10-13 |
2006-09-19 |
Advancis Pharmaceutical Corporation |
Antineoplastic product, use and formulation thereof
|
|
US7157095B2
(en)
|
2000-10-13 |
2007-01-02 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release antifungal product, use and formulation thereof
|
|
US7074417B2
(en)
|
2000-10-13 |
2006-07-11 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-viral product, use and formulation thereof
|
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
|
US6565873B1
(en)
|
2000-10-25 |
2003-05-20 |
Salvona Llc |
Biodegradable bioadhesive controlled release system of nano-particles for oral care products
|
|
US6497901B1
(en)
|
2000-11-02 |
2002-12-24 |
Royer Biomedical, Inc. |
Resorbable matrices for delivery of bioactive compounds
|
|
US7008633B2
(en)
*
|
2000-12-18 |
2006-03-07 |
Board Of Regents, The University Of Texas System |
Local regional chemotherapy and radiotherapy using in situ hydrogel
|
|
GB0102342D0
(en)
*
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
US20020119168A1
(en)
|
2001-02-20 |
2002-08-29 |
Rudnic Edward M. |
Therapeutic agent delivery
|
|
US20020197314A1
(en)
|
2001-02-23 |
2002-12-26 |
Rudnic Edward M. |
Anti-fungal composition
|
|
EP1368000A4
(en)
|
2001-03-13 |
2004-12-01 |
Penwest Pharmaceuticals Co |
CHRONOTHERAPEUTIC PHARMACEUTICAL FORMS CONTAINING A GLUCOCORTICOSTEROID
|
|
AU2002256092C1
(en)
*
|
2001-04-05 |
2009-10-15 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
US6777420B2
(en)
|
2001-06-15 |
2004-08-17 |
Microbiotix, Inc. |
Heterocyclic antibacterial compounds
|
|
US6585997B2
(en)
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
|
US20030124196A1
(en)
|
2001-08-22 |
2003-07-03 |
Susan Weinbach |
Pulsatile release compositions and methods for enhanced intestinal drug absorption
|
|
US6669955B2
(en)
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
|
CA2458644A1
(en)
*
|
2001-08-28 |
2003-03-13 |
Pharmacia Corporation |
Crystaline clindamycin free base
|
|
US6673369B2
(en)
*
|
2001-08-29 |
2004-01-06 |
Ranbaxy Laboratories Limited |
Controlled release formulation
|
|
US6642276B2
(en)
|
2001-10-01 |
2003-11-04 |
M/S Ind-Swift Limited |
Controlled release macrolide pharmaceutical formulations
|
|
US9358214B2
(en)
*
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
JP4845340B2
(ja)
|
2001-10-29 |
2011-12-28 |
マサチューセッツ インスティテュート オブ テクノロジー |
三次元プリント投薬形態のような物品の一軸圧縮のためのシステムおよび方法
|
|
US7300668B2
(en)
|
2001-10-29 |
2007-11-27 |
Massachusetts Institute Of Technology |
System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
|
|
US20030091627A1
(en)
|
2001-10-31 |
2003-05-15 |
Vinay Sharma |
Rate-controlled delivery of macrolides
|
|
AU2002357366A1
(en)
|
2001-12-20 |
2003-07-09 |
Pharmacia Corporation |
Multiple-pulse extended release formulations of clindamycin
|
|
US6682759B2
(en)
*
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
CA2477044A1
(en)
|
2002-02-22 |
2003-09-04 |
Pharmacia Corporation |
Ophthalmic formulation with gum system
|
|
CN1652753A
(zh)
|
2002-04-03 |
2005-08-10 |
兰贝克赛实验室有限公司 |
具有改进的生物利用度的克拉霉素制剂
|
|
WO2003105810A1
(en)
*
|
2002-06-14 |
2003-12-24 |
Andrx Corporation |
Pharmaceutical compositions for drugs having ph-dependentsolubility
|
|
US20040033262A1
(en)
*
|
2002-08-19 |
2004-02-19 |
Orchid Health Care |
Sustained release pharmaceutical composition of a cephalosporin antibiotic
|
|
US20040091528A1
(en)
|
2002-11-12 |
2004-05-13 |
Yamanouchi Pharma Technologies, Inc. |
Soluble drug extended release system
|
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
|
WO2004089299A2
(en)
|
2003-04-02 |
2004-10-21 |
Advancis Pharmaceutical Corporation |
Pulsatile transdermally administered antigens and adjuvants
|
|
CA2529746C
(en)
*
|
2003-06-16 |
2010-08-03 |
Andrx Pharmaceuticals, Llc |
Oral extended-release composition
|
|
US20050053658A1
(en)
*
|
2003-09-09 |
2005-03-10 |
Venkatesh Gopi M. |
Extended release systems for macrolide antibiotics
|
|
US7455840B2
(en)
|
2003-11-19 |
2008-11-25 |
The Scripps Research Institute |
Compositions and methods to reduce mutagenesis
|
|
WO2005070940A2
(en)
|
2004-01-13 |
2005-08-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin derivatives effective against drug-resistant microbes
|
|
US7238694B2
(en)
|
2004-01-13 |
2007-07-03 |
Cumbre Pharmaceuticals, Inc. |
Rifamycin imino derivatives effective against drug-resistant microbes
|
|
US7265107B2
(en)
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
|
US7256187B2
(en)
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
|
US7250413B2
(en)
|
2004-04-26 |
2007-07-31 |
Cumbre Pharmaceuticals Inc. |
C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes
|
|
US7202246B2
(en)
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
|
JP5236944B2
(ja)
*
|
2004-07-22 |
2013-07-17 |
カムブァ、アイピー、ヴェンチュァズ、エル、ピー |
微生物感染を治療するためのリファマイシン誘導体
|